Family Legacy Inc. Takes Position in Danaher Corporation $DHR

Key Points

• Family Legacy Inc. acquired 6,040 shares of Danaher during the second quarter, valued at approximately $1.15 million. Several other institutional investors also initiated or expanded positions, with institutions collectively owning 79.05% of the company.
• Danaher reported quarterly EPS of $1.94, exceeding the $1.85 analyst consensus, while revenue reached $6.26 billion and increased 5.5% year over year.
• Analysts maintain a generally positive outlook, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $228.91, compared with a recent opening price of $202.51.

Family Legacy Inc. acquired a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,040 shares of the conglomerate's stock, valued at approximately $1,150,000.

A number of other large investors have also added to or reduced their stakes in the stock. Clearstead Trust LLC purchased a new stake in Danaher during the 2nd quarter valued at $720,000. Bridgewater Advisors Inc. bought a new stake in shares of Danaher in the second quarter worth $1,153,000. SFE Investment Counsel bought a new stake in shares of Danaher in the second quarter worth $7,376,000. Investors Research Corp increased its position in Danaher by 28,000.0% during the second quarter. Investors Research Corp now owns 2,810 shares of the conglomerate's stock valued at $535,000 after acquiring an additional 2,800 shares during the last quarter. Finally, Tema ETFs LLC increased its position in Danaher by 6.2% during the second quarter. Tema ETFs LLC now owns 19,114 shares of the conglomerate's stock valued at $3,641,000 after acquiring an additional 1,114 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Stock Down 0.7%

NYSE DHR opened at $202.51 on Friday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $142.37 billion, a P/E ratio of 35.97, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The stock's 50-day moving average price is $193.14 and its 200-day moving average price is $193.21.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm's revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.77 EPS. On average, equities research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Ratings Changes

DHR has been the topic of several research reports. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a research report on Wednesday, June 3rd. Piper Sandler began coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price objective on the stock. Royal Bank Of Canada raised their price objective on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, July 22nd. DZ Bank assumed coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a "buy" rating and a $210.00 target price for the company. Finally, Argus decreased their price target on shares of Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research report on Friday, April 24th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source